NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

A Multicenter Placebo-Controlled Double-Blind Trial to Evaluate Azidothymidine (AZT) Treatment of the AIDS Dementia Complex and Central Nervous System (CNS) Human Immunodeficiency Virus (HIV) Infection

Phase 3

Completed

Conditions: HIV Infections
AIDS Dementia Complex

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-03

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 315

Registration Number: NCT00000702

Locations: 🇺🇸
Louisiana State Univ Med Ctr / Tulane Med School, New Orleans, Louisiana, United States
🇺🇸
Charity Hosp / Tulane Univ Med School, New Orleans, Louisiana, United States
🇺🇸
Julio Arroyo, West Columbia, South Carolina, United States

and more 18 locations

A Phase I Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-HIV Envelope Recombinant Vaccine (HIVAC-1e) in Combination With Soluble Recombinant Envelope Vaccine (VaxSyn)

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-02

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 13

Registration Number: NCT00000631

Locations: 🇺🇸
Children's Hospital & Medical Center / Seattle ACTU, Seattle, Washington, United States

Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection

Not Applicable

Completed

Conditions: Tuberculosis
HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-02

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 2000

Registration Number: NCT00000638

Locations: 🇺🇸
Moses H Cone Memorial Hosp, Greensboro, North Carolina, United States
🇺🇸
State of MD Div of Corrections / Johns Hopkins Univ Hosp, Baltimore, Maryland, United States
🇺🇸
Johns Hopkins Hosp, Baltimore, Maryland, United States

and more 73 locations

Evaluation of Patients Who Have Not Had Success With Zidovudine

Phase 2

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-01

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 120

Registration Number: NCT00001025

Locations: 🇺🇸
SUNY / Health Sciences Ctr at Brooklyn, Brooklyn, New York, United States
🇺🇸
Baystate Med Ctr of Springfield, Springfield, Massachusetts, United States
🇺🇸
Univ of Alabama at Birmingham, Birmingham, Alabama, United States

and more 15 locations

Growth Hormone Treatment of Children With HIV-Associated Growth Failure

Not Applicable

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-01

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 102

Registration Number: NCT00006143

Locations: 🇺🇸
Childrens Hosp. LA - Dept. of Ped., Div. of Clinical Immunology & Allergy, Los Angeles, California, United States
🇺🇸
South Florida CDC Ft Lauderdale NICHD CRS, Fort Lauderdale, Florida, United States
🇺🇸
Emory Univ. School of Medicine, Dept. of Peds., Div. of Infectious Diseases, Atlanta, Georgia, United States

and more 17 locations

Active Immunization of HIV-Infected Pregnant Women: A Phase I Study of Safety and Immunogenicity of a rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)

Phase 1

Withdrawn

Conditions: HIV Infections
HIV Seronegativity
Pregnancy

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-01

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Registration Number: NCT00001046

A Study of Nonoxynol-9 (N-9) and HIV Infection

Phase 3

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-10-29

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 4400

Registration Number: NCT00000926

Locations: 🇺🇸
Julia Welch, Research Triangle Park, North Carolina, United States

A Study to Evaluate the Effects of Interleukin-12 (rhIL-12) in HIV-Positive Patients With CD4 Cell Counts Less Than 50 Cells/mm3 or 300-500 Cells/mm3

Phase 1

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-10-29

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 65

Registration Number: NCT00000857

Locations: 🇺🇸
UCLA CARE Center CRS, Los Angeles, California, United States
🇺🇸
USC CRS, Los Angeles, California, United States
🇺🇸
Harbor-UCLA Med. Ctr. CRS, Torrance, California, United States

and more 13 locations

A Study to See If Taking One or Two Extra Drugs Can Lower HIV Levels in Patients Who Have Failed Their Anti-HIV Drug Treatment

Phase 2

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-11-01

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 42

Registration Number: NCT00006152

Locations: 🇺🇸
Beth Israel Deaconess - West Campus, Boston, Massachusetts, United States
🇺🇸
Univ of Texas Galveston, Galveston, Texas, United States
🇺🇸
Univ of Southern California / LA County USC Med Ctr, Los Angeles, California, United States

and more 10 locations

A Study of the Effectiveness of Different Anti-HIV Treatments in HIV-Positive Individuals Who Have Been on a Protease Inhibitor-Containing Drug Regimen for at Least 16 Weeks

Not Applicable

Completed

Conditions: HIV Infections

First Posted Date: 2001-08-31

Last Posted Date: 2021-10-29

Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Target Recruit Count: 800

Registration Number: NCT00000914

Locations: 🇺🇸
North Jersey Community Research Initiative, Newark, New Jersey, United States
🇺🇸
Community Consortium / UCSF, San Francisco, California, United States
🇺🇸
AIDS Research Consortium of Atlanta, Atlanta, Georgia, United States

and more 12 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy